Live Breaking News & Updates on சிஇஓ ஆஃப் ப்ண்ப் வெஸ்பர் வாழ்க்கை அறிவியல்

Kochi-based pharma firm s new drug shows promising results against COVID-19
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore
PB Jayakumar | February 22, 2021 | Updated 15:08 IST
GPP-Baladol, a novel chemical entity (NCE) being developed by pharmaceutical research firm PNB Vesper Life Science for treating Covid-19 patients, claims to have shown promising results in the Phase 2b clinical trials. The pharma firm will soon seek Indian drug regulators approval for emergency use in the country.  
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore. The clinical trial report will be submitted to the DCGI today seeking for an Emergency Use Authorisation to treat hospitalised patients in the country in a ....

United Kingdom , Eric Lattman , Research Institute , Bj Government Medical College , Victoria Medical College , Vesper Life Sciences , Life Science , Medical College , Sassoon General Hospital Pune , Emergency Use Authorisation , Drug Controller General , Vice President , Mask Monitoring , Pnb Wesper Nce For Covid 19 Treatment , Pn Balaram , Ceo Of Pnb Vesper Life Sciences , Victoria Medical College And Research Institute Bangalore , Drug Controller General Of India , ஒன்றுபட்டது கிஂக்டம் , ஆராய்ச்சி நிறுவனம் , பி.ஜே. அரசு மருத்துவ கல்லூரி , விக்டோரியா மருத்துவ கல்லூரி , வெஸ்பர் வாழ்க்கை அறிவியல் , வாழ்க்கை அறிவியல் , மருத்துவ கல்லூரி , சசூன் ஜநரல் மருத்துவமனை புனே ,